Skip to main content

CORRECTION article

Front. Microbiol., 25 October 2023
Sec. Infectious Agents and Disease
Volume 14 - 2023 | https://doi.org/10.3389/fmicb.2023.1304196
This article is part of the Research Topic New advances in the biology and pathogenesis of free-living amoebae View all 13 articles

Corrigendum: Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes

This article is a correction to:

  1. Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes

    1. Read original article
\r\nLori Ferrins Lori Ferrins1*Melissa J. BuskesMelissa J. Buskes1Madison M. KapteynMadison M. Kapteyn2Hannah N. EngelsHannah N. Engels2Suzanne E. Enos,Suzanne E. Enos2,3Chenyang LuChenyang Lu4Dana M. KlugDana M. Klug1Baljinder SinghBaljinder Singh1Antonio Quotadamo,Antonio Quotadamo1,5Kelly BachovchinKelly Bachovchin1Westley F. TearWestley F. Tear1Andrew E. SpauldingAndrew E. Spaulding1Katherine C. ForbesKatherine C. Forbes1Seema BagSeema Bag1Mitch RiversMitch Rivers1Catherine LeBlancCatherine LeBlanc1Erin BurchfieldErin Burchfield1Jeremy R. ArmandJeremy R. Armand1Rosario Diaz-GonzalezRosario Diaz-Gonzalez6Gloria Ceballos-PerezGloria Ceballos-Perez6Raquel García-HernndezRaquel García-Hernández6Guiomar Prez-MorenoGuiomar Pérez-Moreno6Cristina Bosch-NavarreteCristina Bosch-Navarrete6Claudia Gmez-LinClaudia Gómez-Liñán6Luis Miguel Ruiz-PrezLuis Miguel Ruiz-Pérez6Francisco GamarroFrancisco Gamarro6Dolores Gonzlez-PacanowskaDolores González-Pacanowska6Miguel NavarroMiguel Navarro6Kojo Mensa-WilmotKojo Mensa-Wilmot7Michael P. PollastriMichael P. Pollastri1Dennis E. KyleDennis E. Kyle2Christopher A. Rice,, &#x;Christopher A. Rice2,3,4*†
  • 1Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA, United States
  • 2Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, United States
  • 3Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA, United States
  • 4Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, IN, United States
  • 5Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy
  • 6Instituto de Parasitología y Biomedicina “López-Neyra” Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain
  • 7Department of Molecular and Cellular Biology, Kennesaw State University, Kennesaw, GA, United States

A corrigendum on
Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes

by Ferrins, L., Buskes, M. J., Kapteyn, M. M., Engels, H. N., Enos, S. E., Lu, C., Klug, D. M., Singh, B., Quotadamo, A., Bachovchin, K., Tear, W. F., Spaulding, A. E., Forbes, K. C., Bag, S., Rivers, M., LeBlanc, C., Burchfield, E., Armand, J. R., Diaz-Gonzalez, R., Ceballos-Perez, G., García-Hernández, R., Pérez-Moreno, G., Bosch-Navarrete, C., Gómez-Liñán, C., Ruiz-Pérez, L. M., Gamarro, F., González-Pacanowska, D., Navarro, M., Mensa-Wilmot, K., Pollastri, M. P., Kyle, D. E., and Rice, C. A. (2023). Front. Microbiol. 14, 1149145. doi: 10.3389/fmicb.2023.1149145

In the published article, there was an error in the author list, and author “Claudia Gómez-Liñán” was erroneously excluded. The corrected author list appears below.

Lori Ferrins1*, Melissa J. Buskes1, Madison M. Kapteyn2, Hannah N. Engels2, Suzanne E. Enos2,3, Chenyang Lu4, Dana M. Klug1, Baljinder Singh1, Antonio Quotadamo1,5, Kelly Bachovchin1, Westley F. Tear1, Andrew E. Spaulding1, Katherine C. Forbes1, Seema Bag1, Mitch Rivers1, Catherine LeBlanc1, Erin Burchfield1, Jeremy R. Armand1, Rosario Diaz-Gonzalez6, Gloria Ceballos-Perez6, Raquel García-Hernández6, Guiomar Pérez-Moreno6, Cristina Bosch-Navarrete6, Claudia Gómez-Liñán6, Luis Miguel Ruiz-Pérez6, Francisco Gamarro6, Dolores González-Pacanowska6, Miguel Navarro6, Kojo Mensa-Wilmot7, Michael P. Pollastri1, Dennis E. Kyle2 and Christopher A. Rice2,3,4*†

In the original article there was also an error in the Author Contribution section.

The correct author contributions section appears below:

Author contributions

CR, MB, and LF: conceptualization. LF, MB, MK, HE, SE, CLu, DKl, BS, AQ, KB, WT, AS, KF, SB, MR, CLe, EB, JA, RD-G, GC-P, GP-M, CB-N, CG-L, DG-P, MN, and CR: methodology. CR, DKy, MP, and LF: validation and supervision. LF and CR: formal analysis and writing—original draft preparation. DKy, MP, and LF: resources and funding acquisition. LF, MB, DKl, BS, KB, WT, SB, MK, HE, SE, CLu, CB-N, and CR: data curation. LF, MB, MK, HE, SE, CLu, DKl, BS, AQ, KB, WT, AS, KF, SB, MR, CLe, EB, JA, RD-G, GC-P, RG-H, GP-M, CB-N, CG-L, LR-P, FG, DG-P, MN, KM-W, MP, DKy, and CR: writing—review and editing. All authors contributed to the article and approved the submitted version.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: pathogenic free-living amoeba, Acanthamoeba species, Naegleria fowleri, Balamuthia mandrillaris, kinase inhibitors, cross-screening, hit-identification

Citation: Ferrins L, Buskes MJ, Kapteyn MM, Engels HN, Enos SE, Lu C, Klug DM, Singh B, Quotadamo A, Bachovchin K, Tear WF, Spaulding AE, Forbes KC, Bag S, Rivers M, LeBlanc C, Burchfield E, Armand JR, Diaz-Gonzalez R, Ceballos-Perez G, García-Hernández R, Pérez-Moreno G, Bosch-Navarrete C, Gómez-Liñán C, Ruiz-Pérez LM, Gamarro F, González-Pacanowska D, Navarro M, Mensa-Wilmot K, Pollastri MP, Kyle DE and Rice CA (2023) Corrigendum: Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes. Front. Microbiol. 14:1304196. doi: 10.3389/fmicb.2023.1304196

Received: 29 September 2023; Accepted: 02 October 2023;
Published: 25 October 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Ferrins, Buskes, Kapteyn, Engels, Enos, Lu, Klug, Singh, Quotadamo, Bachovchin, Tear, Spaulding, Forbes, Bag, Rivers, LeBlanc, Burchfield, Armand, Diaz-Gonzalez, Ceballos-Perez, García-Hernández, Pérez-Moreno, Bosch-Navarrete, Gómez-Liñán, Ruiz-Pérez, Gamarro, González-Pacanowska, Navarro, Mensa-Wilmot, Pollastri, Kyle and Rice. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lori Ferrins, l.ferrins@northeastern.edu; Christopher A. Rice, carice@purdue.edu

†Present address: Christopher A. Rice, Purdue Institute for Drug Discovery (PIDD), Purdue University, West Lafayette, IN, United States; Purdue Institute of Inflammation, Immunology and Infectious Disease (PI4D), Purdue University, West Lafayette, IN, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.